Hyoscine butylbromide - subcutaneous formulations



Codelist metadata

Coding system

Dictionary of Medicines and Devices

Coding system release

unknown

Organisation

OpenSAFELY

Codelist ID

opensafely/hyoscine-butylbromide-subcutaneous-formulations

Version ID

252fefa4

Versions

About

Description

This codelist contains all subcutaneous formulations of hyoscine butylbromide.

Methodology

All AMPs and VMPs from the NHS dm+d have been mapped from relevant BNF codes. No exceptional cases were identified.

References

Signed off by

  • Andrew Brown, (May 31, 2022)
  • Richard Croker, (May 31, 2022)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.

dmd_type dmd_id dmd_name bnf_code
VMP 36044111000001101 Hyoscine butylbromide 20mg/1ml solution for injection ampoules 0102000N0AAAAAA
AMP 3242611000001101 Buscopan 20mg/1ml solution for injection ampoules 0102000N0BBABAA

* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.